海尔生物：截至目前，公司整体海外市场收入占比已超过35%

Core Viewpoint - Haier Biomedical has achieved significant growth in its overseas market, with over 35% of its total revenue coming from international sales, and a year-on-year growth of 20% expected in the first three quarters of 2025 [2] Group 1: Overseas Market Performance - The company has reported high double-digit growth in the European region, contributing to its overall overseas revenue increase [2] - The growth in overseas business is attributed to the company's localized operational system and the continuous expansion of its product categories [2] Group 2: Localization Strategy - Haier Biomedical has established localized operations in 18 countries and set up subsidiaries in the UK, Netherlands, and other locations [2] - The company focuses on understanding local user needs and employs localized planning, marketing, warehousing, and services to address core user pain points [2] Group 3: Brand Development - The company aims to become a globally trusted brand in life sciences, with a significant increase in overseas revenue, achieving a compound annual growth rate of over 20% from 2016 to 2024 [2] - Haier Biomedical's business now covers over 150 countries and regions worldwide, showcasing its extensive market reach [2]